Assenagon Asset Management S.A. Has $10.81 Million Position in CorVel Corp. $CRVL

Posted by Brenda Bartman on Jun 28th, 2026

Assenagon Asset Management S.A. lifted its position in shares of CorVel Corp. (NASDAQ:CRVL – Free Report) by 14.7% in the first quarter, Holdings Channel reports. The institutional investor owned 197,858 shares of the business services provider’s stock after acquiring an additional 25,366 shares during the period. Assenagon Asset Management S.A.’s holdings in CorVel were worth $10,813,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. bought a new stake in CorVel in the 3rd quarter valued at about $31,000. Los Angeles Capital Management LLC acquired a new stake in shares of CorVel in the fourth quarter valued at approximately $33,000. Eagle Bay Advisors LLC acquired a new stake in shares of CorVel in the fourth quarter valued at approximately $37,000. Rockefeller Capital Management L.P. boosted its stake in shares of CorVel by 66.9% in the fourth quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider’s stock valued at $39,000 after buying an additional 230 shares during the period. Finally, Quarry LP grew its position in CorVel by 218.6% during the third quarter. Quarry LP now owns 513 shares of the business services provider’s stock worth $40,000 after buying an additional 352 shares in the last quarter. Institutional investors own 51.36% of the company’s stock.

CorVel Trading Up 2.0%

CorVel stock opened at $62.99 on Friday. The company has a market capitalization of $3.19 billion, a PE ratio of 29.43 and a beta of 0.99. CorVel Corp. has a 12 month low of $44.83 and a 12 month high of $105.50. The stock has a 50-day moving average price of $59.07 and a two-hundred day moving average price of $59.39.

CorVel (NASDAQ:CRVL – Get Free Report) last released its quarterly earnings results on Tuesday, May 19th. The business services provider reported $0.61 earnings per share (EPS) for the quarter. The firm had revenue of $248.55 million during the quarter. CorVel had a net margin of 11.51% and a return on equity of 29.92%.

Analyst Ratings Changes

CRVL has been the subject of a number of recent analyst reports. Wall Street Zen upgraded CorVel from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Weiss Ratings downgraded CorVel from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, April 6th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, CorVel currently has a consensus rating of “Sell”.

Check Out Our Latest Report on CorVel

Insider Activity

In other CorVel news, insider Maxim Shishin sold 2,250 shares of CorVel stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $60.59, for a total value of $136,327.50. Following the completion of the sale, the insider directly owned 7,050 shares in the company, valued at approximately $427,159.50. The trade was a 24.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Jennifer Yoss sold 1,999 shares of CorVel stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $61.02, for a total transaction of $121,978.98. Following the completion of the sale, the vice president directly owned 2,173 shares of the company’s stock, valued at approximately $132,596.46. This trade represents a 47.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 13,249 shares of company stock valued at $807,126 in the last ninety days. 44.56% of the stock is owned by company insiders.

About CorVel

(Free Report)

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).